⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
HALO News
Halozyme Therapeutics, Inc.
Dr. Alison Armour agrees to become Chief Medical Officer of Alpha Fusion, as Company Advances Integration of At-211 Businesses with Curadh MTR
prnewswire.com
AZN
NVS
HALO
Form 8-K
sec.gov
HALO
Halozyme Therapeutics, Inc. Announces Proposed Offering of $1.05 Billion of Convertible Senior Notes due 2033
prnewswire.com
HALO
Liberty All-Star ® Growth Fund, Inc. August 2026 Monthly Update
businesswire.com
NVDA
GOOGL
HALO
MSFT
AAPL
META
ASMB
MPWR
EAT
AXON
DDOG
MDB
LLY
RJF
YOU
CGNX
MTRN
LRCX
VERA
WSM
COHR
DHI
KLIC
MOD
UTI
Halozyme to Participate at Upcoming Investor Conferences
prnewswire.com
HALO
Medical Image Analysis Software Market worth $6.42 billion by 2031 - Exclusive Report by MarketsandMarkets™
prnewswire.com
GEHC
HALO
BRKR
MSFT
XRAY
NNOX
Form 8-K
sec.gov
HALO
Halozyme Appoints Dannielle Appelhans to its Board of Directors
prnewswire.com
HALO
Kenai Therapeutics Appoints Mark Gergen to Board of Directors
prnewswire.com
HALO
AMGN
Haloid Connects ChatGPT Voice AI to Analog Two-Way Radios, Bridging AI and Mission-Critical Land Mobile Radio
prnewswire.com
HALO